GridAI Technologies Corp. Common Stock

GRDXNASDAQ • USD
4.19 USD
↗ 0.45 (11.90%)🟢LIVE (AS OF 11:24 AM EST)
🟢Market: OPEN

GRDX is currently priced at $4.19. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$3.83
High?$4.21
Low?$3.83
Prev. Close?$3.74
Volume?170.4K
Avg. Volume?121.8K
VWAP?$4.05
Rel. Volume?1.40x
Bid / Ask
Bid?$3.50 × 100
Ask?$4.69 × 100
Spread?$1.19
Midpoint?$4.10
Valuation & Ratios
Market Cap?33.2M
Shares Out?7.1M
Float?6.3M
Float %?87.9%
P/E Ratio?N/A
P/B Ratio?3.30
EPS?-$2.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Employees
2
Market Cap
33.2M
Industry
ELECTRIC & OTHER SERVICES COMBINED
Listed
2016-10-11
Address
433 PLAZA REAL
BOCA RATON, FL
Phone: 561-589-7020
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.49%Low
Short Interest?30.5K
Days to Cover?1.0
Free Float6.3M
Avg Daily Volume116.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.16Weak
Cash Ratio?0.10Low
Debt/Equity?0.17Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
51
3.30FAIR▾
P/S?
Peers
100
S&P
3
207.34HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
209.19HIGH▾
Returns & Efficiency
ROE?
S&P
3
-206.6%WEAK▾
ROA?
S&P
3
-56.3%WEAK▾
Cash Flow & Enterprise
FCF?$-8120882
Enterprise Value?$33.5M
Fundamentals ratios updated end of day